- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01610986
Effects of Glucose-fructose Drinks During Training on Lactate Transport (LactEx)
June 3, 2014 updated by: Luc Tappy, MD, University of Lausanne
Effects of Glucose-fructose Drinks During Training on Lactate Transport and Oxidation and on Endurance Performance
The purpose of this study is to determine whether glucose-fructose intake during training increases lactate transport and oxidation and improve endurance performance.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study will enroll 24 healthy male volunteers.
After baseline assessment of lactate transport and endurance performance, subjects will be randomized to either a 3-week intervention arm in which they will train with glucose-fructose intake during training, or to a control arm (water during training).
After this 3-week intervention, lactate transport and endurance performance will be assessed again.
Study Type
Interventional
Enrollment (Actual)
17
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Vaud
-
Lausanne, Vaud, Switzerland, 1005
- University of Lausanne
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- healthy
- age between 18 and 30 years
- sedentary
- BMI between 19 and 25
- blood pressure lower than 140/90 mmHg
Exclusion Criteria:
- smoking
- consumption of more than 10g alcohol per day
- cardiovascular history
- electrographic abnormalities at rest
- consumption of more than one can of soda per day or more than 60g sugars per day
- any current drug treatment
- consumption of drugs or illicit substances
- diabetes mellitus
- vegetarian
- food intolerance
- blood donation or participation to another study <3 months before study inclusion
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Glucose-fructose
Participants will take glucose-fructose drinks during training sessions
|
0.8 g/h glucose and 0.5 g/h fructose during training
|
Experimental: Water
Participants will take only water during training sessions
|
Only water intake during training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in lactate transport
Time Frame: At baseline (before training) and after the 3-week training protocol
|
Measurement of lactate production, utilization, oxidation and clearance during a 90 min cycling exercise at 50% VO2 max (measured with 13C-lactate)
|
At baseline (before training) and after the 3-week training protocol
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in muscle monocarboxylate transporters (MCTs) expression and protein content
Time Frame: At baseline (before training) and after the 3-week training protocol
|
MCTs expression (mRNA) and protein content after muscle biopsy
|
At baseline (before training) and after the 3-week training protocol
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Luc Tappy, Pr, University of Lausanne
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2012
Primary Completion (Actual)
March 1, 2014
Study Completion (Actual)
March 1, 2014
Study Registration Dates
First Submitted
May 23, 2012
First Submitted That Met QC Criteria
May 30, 2012
First Posted (Estimate)
June 4, 2012
Study Record Updates
Last Update Posted (Estimate)
June 4, 2014
Last Update Submitted That Met QC Criteria
June 3, 2014
Last Verified
June 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- 251/11
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Normal Physiology on Healthy Subjects
-
National Institute of Allergy and Infectious Diseases...RecruitingHealthy | Normal PhysiologyUnited States
-
National Institute of Neurological Disorders and...Completed
-
Halia Therapeutics, Inc.TKL Research, Inc.Completed
-
Tetraphase Pharmaceuticals, Inc.Completed
-
Yonsei UniversityUnknownNormal Healthy SubjectsKorea, Republic of
-
Yonsei UniversityCompletedNormal Healthy SubjectsKorea, Republic of
-
Taiwan Liposome CompanyCompleted
-
SunovionCompletedMale, Healthy Normal SubjectsUnited States
-
National Center for Complementary and Integrative...RecruitingPain | Healthy Volunteers | Normal PhysiologyUnited States
-
National Center for Complementary and Integrative...RecruitingPain | Healthy Volunteers | Normal PhysiologyUnited States
Clinical Trials on Glucose-fructose
-
Rockefeller UniversityThe Rogosin InstituteCompletedCardiovascular Disease | Diabetes | Elevated TriglyceridesUnited States
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompletedCardiovascular Disease | Diabetes | Dyslipidemia | Elevated TriglyceridesUnited States
-
Pennington Biomedical Research CenterUSDA Beltsville Human Nutrition Research CenterCompletedBody Weight ChangesUnited States
-
University Health Network, TorontoCompleted
-
The Rogosin InstituteUniversity of Missouri-Columbia; Weill Medical College of Cornell UniversityTerminatedAdolescent ObesityUnited States
-
Oregon Health and Science UniversityCompletedObesityUnited States
-
NestléCompletedHealthyNew Zealand
-
Unilever R&DLeiden University Medical CenterCompleted
-
Unilever R&DLeiden University Medical CenterCompleted
-
University Hospital, Basel, SwitzerlandCompletedExploratory BehaviorSwitzerland